Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AGfiledCriticalCiba Geigy AG
Priority to ES557254ApriorityCriticalpatent/ES8708217A1/en
Publication of ES557254A0publicationCriticalpatent/ES557254A0/en
Publication of ES8708217A1publicationCriticalpatent/ES8708217A1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Fluorinated resorcinols of formula (I) and their alkali (ne earth) and transition metal salts are new, where R2 = 3,3,3-trifluoropropyl R3 = H, lower alkoxy, CF3 or halogen R11 = H or R,CO and R1 = lower alkyl. Ethers of formula (II) are new. R2 = fluorinated lower alkyl alk = 1-9C (hydroxy)alkylene opt. interrupted by O one of R4, R5 and R7 = NHCOR8 R4 and R5 when different from this are H, lower alkyl, lower alkoxy, halogen or CF3, and R7 differing from this is as given fro R4 and R5 or CN or COOH opt. esterified or amidated. In (I), R2 is fluorinated lower alkyl.
Tetra-alkyl-2,2,5,5-cyclohexanon-4-ol-1 and its sulfonated derivatives, process and intermediates for its preparation and its use in the synthesis of cis-cyclopropanlactones